The CRISPR (clustered regularly interspaced palindromic repeats) technology is based on a bacterial defense pathway against viral invasion. It has been adapted for genome editing applications in eukaryotic cells and is an emerging technology because it allows for some more flexibility compared to zinc finger nucleases (ZFNs) or transcriptional activator-like effector nucleases (TALENs).